Llwytho...
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
BACKGROUND: Non‐absorbable disaccharides (lactulose and lactitol) are recommended as first‐line treatment for hepatic encephalopathy. The previous (second) version of this review included 10 randomised clinical trials (RCTs) evaluating non‐absorbable disaccharides versus placebo/no intervention and...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cochrane Database Syst Rev |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley & Sons, Ltd
2016
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004252/ https://ncbi.nlm.nih.gov/pubmed/27153247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003044.pub4 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|